Jason Hoitt, Chief Commercial Officer at Dova Pharmaceuticals Inc. (DOVA), sold 2,387 shares at $28.00 ($67K) on 2019-09-30, disclosed to the SEC on 2019-10-02.
Open-market sale of $67k DOVA by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PRVB | BUY | 2020-03-20 | $24K | — | Filing → |
| DOVA | SELL | 2019-07-16 | $116K | — | Filing → |
| DOVA | SELL | 2019-07-02 | $33K | — | Filing → |